<DOC>
	<DOC>NCT01629225</DOC>
	<brief_summary>The purpose of this study is to investigate the association between GRK4 polymorphisms and essential hypertension in southwestern Han Chinese and test whether these polymorphisms were associated with the changes in blood pressure in patients with essential hypertension treated with angiotensin II Type antagonist candesartan.</brief_summary>
	<brief_title>GRK4 Polymorphisms Blood Pressure Response to Candesartan</brief_title>
	<detailed_description>All antihypertensive agents were withdrawn before the start of a 4-6 week, single-blind, after which the patients received candesartan 10 mg or 20mg once daily as monotherapy in a single-blind fashion. The doses were doubled after 1 weeks if DBP was â‰¥ 90 mmHg.</detailed_description>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>men and women with mild to moderate essential hypertension in southwestern Han Chinese subjects unwilling to participate or subjects did not have all measurement required, subjects who were on medications, which affect blood pressure or whose DNA failed to amplify and 8 with errors in Mendelian segregation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>men and women</keyword>
	<keyword>in southwestern Han Chinese</keyword>
</DOC>